Biological sex, inherited factors and menopause significantly influence the likelihood of developing Alzheimer's disease, the body's response to treatment and the course of chronic pain syndromes, including fibromyalgia. The findings come from four studies presented at the annual meeting of the Society for Neuroscience, Neuroscience 2026, according to infohub.kz.

Sex differences and hormonal shifts largely determine the brain's vulnerability to neurodegeneration, the effectiveness of treatment and immune system activity in fibromyalgia, the research indicates.

Two of the studies focused on the link between menopause, heredity and Alzheimer's disease. Matea Perovic of the University of Toronto found that people with genetic risk factors for the disease respond differently to menopausal hormone therapy than others, with the outcome depending on the specific combination of hormones.

In another study, Stephanie Perez of the University of Texas Health Science Center at San Antonio showed in genetically predisposed rodents that the neural circuits responsible for memory become especially vulnerable during menopause.

Two other studies shed light on the role of biological sex in the mechanisms of inflammation and chronic pain. In a mouse model of fibromyalgia, researcher Yasmin Sahloul of the University of Cincinnati found that females had higher sensitivity to touch and stronger immune system activation than males.

Nurkan Kilic of the University of North Dakota, meanwhile, found that prolonged intestinal inflammation in mice affects brain function and Alzheimer's-related changes differently in males and females.

According to the press conference moderator, Dr. Lisa Galea of the Centre for Addiction and Mental Health, accounting for sex differences will help create more precise treatments for complex neurological disorders.